Back to Search
Start Over
Anti-inflammatory and anti-lung cancer activities of low-molecular-weight and high-sulfate-content sulfated polysaccharides extracted from the edible fungus Poria cocos.
- Source :
-
International journal of biological macromolecules [Int J Biol Macromol] 2024 Nov; Vol. 279 (Pt 4), pp. 135483. Date of Electronic Publication: 2024 Sep 10. - Publication Year :
- 2024
-
Abstract
- Sulfated polysaccharides (SPSs) have excellent physicochemical properties, attracting research interest in the pharmaceutical industry. A previous study extracted SPS (named Suc40) from the edible fungus, Poria cocos and demonstrated that it exhibited anti-inflammatory and anticancer activities. In this study, three fractions of Suc40, Suc40 F1, Suc40 F2, and Suc40 F3, with different molecular weights and sulfate contents were prepared through gel-filtration column chromatography. The molecular weights of F1, F2, and F3 were approximately 616.23, 82.57, and 6.21 kDa, respectively, and their sulfate content were 0.23, 1.65, and 1.90 mmol/g, respectively. The fractions' anti-inflammatory activities were determined by assessing their ability to suppress inflammatory cytokines in lipopolysaccharide (LPS)-stimulated RAW264.7 cells. Suc40 F2 and Suc40 F3 suppressed interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) production by 60 % and 35 %, respectively. Suc40 F2 and Suc40 F3 suppressed protein kinase B (AKT)/p38 and p38 signaling, which resulted in anti-inflammatory effects. The fractions' anti-lung cancer activity was evaluated by assessing their H1975 cell proliferation inhibition. Suc40 F3 at a concentration of 800 μg/ml exhibited maximal cell proliferation inhibition. The low molecular weight and high sulfate content of Suc40 F3 were associated with its enhanced anti-inflammatory and anti-lung cancer activities.<br />Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Subjects :
- Mice
Animals
RAW 264.7 Cells
Humans
Fungal Polysaccharides pharmacology
Fungal Polysaccharides chemistry
Fungal Polysaccharides isolation & purification
Polysaccharides pharmacology
Polysaccharides chemistry
Polysaccharides isolation & purification
Interleukin-6 metabolism
Cell Proliferation drug effects
Lipopolysaccharides pharmacology
Cytokines metabolism
Molecular Weight
Anti-Inflammatory Agents pharmacology
Anti-Inflammatory Agents chemistry
Sulfates chemistry
Antineoplastic Agents pharmacology
Antineoplastic Agents chemistry
Lung Neoplasms drug therapy
Lung Neoplasms pathology
Wolfiporia chemistry
Subjects
Details
- Language :
- English
- ISSN :
- 1879-0003
- Volume :
- 279
- Issue :
- Pt 4
- Database :
- MEDLINE
- Journal :
- International journal of biological macromolecules
- Publication Type :
- Academic Journal
- Accession number :
- 39260636
- Full Text :
- https://doi.org/10.1016/j.ijbiomac.2024.135483